188 related articles for article (PubMed ID: 7622821)
1. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
Kasper S; Möller HJ; Montgomery SA; Zondag E
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
[TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
[TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of fluvoxamine in patients with severe depression.
Ottevanger EA
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):731-40. PubMed ID: 7938563
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
Wakelin JS
Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
[TBL] [Abstract][Full Text] [Related]
8. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
Guelfi JD; Dreyfus JF; Pichot P
Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
10. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
[TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
[TBL] [Abstract][Full Text] [Related]
16. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
18. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
Feiger AD
Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
